Asymchem Laboratories (Tianjin) Co., Ltd.
002821
Classement en actions
#2511
Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development... Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development and manufacturing organization (CDMO), offering its expertise to pharmaceutical and biotechnology companies both globally and within Mainland China. Their services encompass drug research, development, and production, supporting projects across the entire drug lifecycle, from early clinical phases to commercial scale. This includes R&D and cGMP-compliant manufacturing of advanced intermediates, active pharmaceutical ingredients (APIs), and finished drug formulations, in addition to providing clinical research support. Furthermore, Asymchem engages in pharmaceutical analysis and testing, the distribution (wholesale, retail, and direct sale) of medicines, and initiatives focused on advancing pharmaceutical science and technology. The company, established in 1999, maintains its headquarters in Tianjin, China.
Prix de l'action
$20.91
Capitalisation boursière
$7.57B
Changement (1 jour)
-8.26%
Changement (1 an)
41.25%
Pays
CN
Échange Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Catégorie
Healthcare
Revenus pour Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Revenus en Jun 2026 TTM : $1.06B
Selon les derniers rapports financiers de Asymchem Laboratories (Tianjin) Co., Ltd., le chiffre d'affaires actuel de l'entreprise (TTM) est de $1.06B. En 2024, l'entreprise a réalisé un chiffre d'affaires de $795.26M une diminution par rapport à le chiffre d'affaires de l'année 2023, qui était de $1.11B. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Asymchem Laboratories (Tianjin) Co., Ltd. de 2011 à 2026
Revenus à la fin de chaque année
| Année | Revenus | Changez |
|---|---|---|
| 2026 (TTM) | $1.06B | 11.34% |
| 2025 | $953.37M | 19.88% |
| 2024 | $795.26M | -28.06% |
| 2023 | $1.11B | -25.46% |
| 2022 | $1.48B | 103.50% |
| 2021 | $728.79M | 51.78% |
| 2020 | $480.16M | 35.91% |
| 2019 | $353.28M | 32.44% |
| 2018 | $266.75M | 21.96% |
| 2017 | $218.72M | 37.65% |
| 2016 | $158.90M | 24.23% |
| 2015 | $127.91M | 10.62% |
| 2014 | $115.63M | 29.23% |
| 2013 | $89.48M | 31.47% |
| 2012 | $68.06M | 5.76% |
| 2011 | $64.35M | 0.00% |
Revenus d’entreprises similaires ou concurrentes
| Entreprise | Revenus | Différence de revenus | Pays |
|---|---|---|---|
| $12.62B | 1,089.29% |
US
|
|
| $2.23B | 109.89% |
US
|
|
| $15.74B | 1,383.22% |
AU
|
|
| $9.57B | 801.80% |
BE
|
|
| $6.02B | 467.25% |
NL
|
